CGON
Price
$26.63
Change
+$0.05 (+0.19%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
2.03B
63 days until earnings call
SNDX
Price
$11.16
Change
+$0.20 (+1.82%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
960.29M
66 days until earnings call
Interact to see
Advertisement

CGON vs SNDX

Header iconCGON vs SNDX Comparison
Open Charts CGON vs SNDXBanner chart's image
CG Oncology
Price$26.63
Change+$0.05 (+0.19%)
Volume$18.18K
Capitalization2.03B
Syndax Pharmaceuticals
Price$11.16
Change+$0.20 (+1.82%)
Volume$69.71K
Capitalization960.29M
CGON vs SNDX Comparison Chart
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. SNDX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Buy and SNDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CGON: $26.64 vs. SNDX: $11.16)
Brand notoriety: CGON and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 74% vs. SNDX: 45%
Market capitalization -- CGON: $2.03B vs. SNDX: $960.29M
CGON [@Biotechnology] is valued at $2.03B. SNDX’s [@Biotechnology] market capitalization is $960.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 6 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 3 bearish.
  • SNDX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +1.56% price change this week, while SNDX (@Biotechnology) price change was +5.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.03B) has a higher market cap than SNDX($960M). CGON YTD gains are higher at: -7.322 vs. SNDX (-15.582). CGON has higher annual earnings (EBITDA): -95.94M vs. SNDX (-318.27M). CGON (541M) and SNDX (516M) have equal amount of cash in the bank . CGON has less debt than SNDX: CGON (296K) vs SNDX (1.84M). SNDX has higher revenues than CGON: SNDX (43.7M) vs CGON (684K).
CGONSNDXCGON / SNDX
Capitalization2.03B960M212%
EBITDA-95.94M-318.27M30%
Gain YTD-7.322-15.58247%
P/E RatioN/AN/A-
Revenue684K43.7M2%
Total Cash541M516M105%
Total Debt296K1.84M16%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONSNDX
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 22 days ago
77%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVFCX4.23N/A
N/A
Federated Hermes Intl Strat Val Div C
WFPAX45.52N/A
N/A
Allspring Special Mid Cap Value A
LMPOX31.74N/A
N/A
ClearBridge Small Cap Growth R
AFAVX13.55N/A
N/A
AMG River Road Focused Absolute Value I
PSCMX16.05N/A
N/A
Putnam Small Cap Value R6

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-0.78%
IDYA - CGON
60%
Loosely correlated
-2.50%
ACLX - CGON
57%
Loosely correlated
+0.52%
SYRE - CGON
57%
Loosely correlated
-0.30%
KRYS - CGON
54%
Loosely correlated
+0.86%
NUVL - CGON
54%
Loosely correlated
-1.74%
More